These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2667102)

  • 21. In-vitro and in-vivo studies of resistance to rifampin in meningococci.
    Eickhoff TC
    J Infect Dis; 1971 Apr; 123(4):414-20. PubMed ID: 4999905
    [No Abstract]   [Full Text] [Related]  

  • 22. Carriage of meningococci in contacts of patients with meningococcal disease. Chemoprophylaxic strategy needs to be determined.
    Dutton P; Winterton ; Wright E; Yeant HS
    BMJ; 1999 Mar; 318(7184):665; author reply 666. PubMed ID: 10215362
    [No Abstract]   [Full Text] [Related]  

  • 23. Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin.
    Cuevas LE; Kazembe P; Mughogho GK; Tillotson GS; Hart CA
    J Infect Dis; 1995 Mar; 171(3):728-31. PubMed ID: 7876629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemoprophylaxis of meningococcal infection.
    Wall RA
    J Antimicrob Chemother; 1988 Jun; 21(6):698-700. PubMed ID: 3045066
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers.
    Dworzack DL; Sanders CC; Horowitz EA; Allais JM; Sookpranee M; Sanders WE; Ferraro FM
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1740-1. PubMed ID: 3252755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprophylaxis against meningococcal infection.
    Robinson P; Spelman D
    Med J Aust; 1993 Jul; 159(2):138-9. PubMed ID: 8336592
    [No Abstract]   [Full Text] [Related]  

  • 27. Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers.
    Devine LF; Hannah JM; Hagerman CR; Rhode SL; Peckinpaugh RO
    Mil Med; 1973 Jan; 138(1):20-4. PubMed ID: 4630051
    [No Abstract]   [Full Text] [Related]  

  • 28. Survey of the prescribing of chemoprophylaxis to index cases of invasive meningococcal disease.
    Heywood P; Holtby I
    Commun Dis Public Health; 2000 Dec; 3(4):271-3. PubMed ID: 11280257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners.
    Marks PJ; Neal KR
    BMC Public Health; 2001; 1():16. PubMed ID: 11806758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
    Carabias ML; Cervera LA; García-Navas BL; entelles ML
    Rev Esp Quimioter; 2001 Jun; 14(2):177-83. PubMed ID: 11704772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic trial of cephalexin in meningococcal carriers.
    Deal WB; Sanders E
    Antimicrob Agents Chemother (Bethesda); 1969; 9():441-4. PubMed ID: 5396522
    [No Abstract]   [Full Text] [Related]  

  • 32. [Outbreak of serogroup C meningococcal disease among teenagers in Randers--preventive measures and examination of the meningococcal carrier conditions].
    Rønne T; Buhl LH; Lind I
    Ugeskr Laeger; 1995 Aug; 157(32):4454-8. PubMed ID: 7483025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In brief: Meningococcal prophylaxis.
    Med Lett Drugs Ther; 2008 Apr; 50(1283):25. PubMed ID: 18391897
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience in carrying out antiepidemic measures in foci of meningococcal infections].
    Pronin AA; Lev MI; Kulikov IA; Mazurin ND; Sergeĭchik II
    Voen Med Zh; 1972 Nov; 11():50-2. PubMed ID: 4648205
    [No Abstract]   [Full Text] [Related]  

  • 35. Meningococcemia update vaccination and chemoprophylaxis.
    Gupta P; Choudhury P
    Indian Pediatr; 2005 Jul; 42(7):641-4. PubMed ID: 16085964
    [No Abstract]   [Full Text] [Related]  

  • 36. [Meningococcal project Telemark. Experiences after 5 years with contact tracing and eradication of the pathogenic bacteria in near contacts of the patients with meningococcal disease].
    Kristiansen BE; Tveten Y; Ask E; Knapskog AB; Reiten T; Steen-Johnsen J; Hopen G
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2933-7. PubMed ID: 8236200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of chemoprophylaxis on the meningococcal carrier state after systemic infection.
    Alvez F; Aguilera A; Garcia-Zabarte A; Castro-Gago M
    Pediatr Infect Dis J; 1991 Sep; 10(9):700. PubMed ID: 1923684
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.
    Prasad K; Karlupia N
    Respir Med; 2007 Oct; 101(10):2037-43. PubMed ID: 17706408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza and meningococcal disease: lessons for travellers and government from 2 epidemic diseases.
    Booy R; El Bashir H; Rashid H; Shingadia D; Haworth E
    Travel Med Infect Dis; 2009 Jul; 7(4):253-6. PubMed ID: 19717110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria.
    Darouiche R; Perkins B; Musher D; Hamill R; Tsai S
    J Infect Dis; 1990 Nov; 162(5):1124-7. PubMed ID: 2121836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.